142 related articles for article (PubMed ID: 9531614)
21. Plasma cytokine and soluble receptor signature predicts outcome of patients with classical Hodgkin's lymphoma: a study from the Groupe d'Etude des Lymphomes de l'Adulte.
Casasnovas RO; Mounier N; Brice P; Divine M; Morschhauser F; Gabarre J; Blay JY; Voillat L; Lederlin P; Stamatoullas A; Bienvenu J; Guiguet M; Intrator L; Grandjean M; Brière J; Ferme C; Salles G;
J Clin Oncol; 2007 May; 25(13):1732-40. PubMed ID: 17389336
[TBL] [Abstract][Full Text] [Related]
22. High soluble CD30 levels and associated anti-HLA antibodies in patients with failed renal allografts.
Karahan GE; Caliskan Y; Ozdilli K; Kekik C; Bakkaloglu H; Caliskan B; Turkmen A; Sever MS; Oguz FS
Int J Artif Organs; 2017 Jan; 39(11):547-552. PubMed ID: 28058698
[TBL] [Abstract][Full Text] [Related]
23. High plasma levels of the soluble form of CD30 activation molecule reflect disease activity in patients with Wegener's granulomatosis.
Wang G; Hansen H; Tatsis E; Csernok E; Lemke H; Gross WL
Am J Med; 1997 Jun; 102(6):517-23. PubMed ID: 9217665
[TBL] [Abstract][Full Text] [Related]
24. High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS.
Pizzolo G; Vinante F; Morosato L; Nadali G; Chilosi M; Gandini G; Sinicco A; Raiteri R; Semenzato G; Stein H
AIDS; 1994 Jun; 8(6):741-5. PubMed ID: 8086130
[TBL] [Abstract][Full Text] [Related]
25. Soluble vascular cell adhesion molecule-1 (sVCAM-1) is an independent prognostic marker in Hodgkin's disease.
Christiansen I; Sundström C; Enblad G; Tötterman TH
Br J Haematol; 1998 Aug; 102(3):701-9. PubMed ID: 9722296
[TBL] [Abstract][Full Text] [Related]
26. Increased serum CD8 antigen level in childhood Hodgkin's disease relates to advanced stage and poor treatment outcome.
Pui CH; Ip SH; Thompson E; Dodge RK; Brown M; Wilimas J; Carrabis S; Kung P; Berard CW; Crist WM
Blood; 1989 Jan; 73(1):209-13. PubMed ID: 2521294
[TBL] [Abstract][Full Text] [Related]
27. Increased serum levels of soluble CD30 in patients with common variable immunodeficiency and its clinical implications.
Rezaei N; Haji-Molla-Hoseini M; Aghamohammadi A; Pourfathollah AA; Moghtadaie M; Pourpak Z
J Clin Immunol; 2008 Jan; 28(1):78-84. PubMed ID: 17912490
[TBL] [Abstract][Full Text] [Related]
28. Plasma levels of soluble CD30 are increased in children with chronic renal failure and with primary growth deficiency and decrease during treatment with recombination human growth hormone.
Barbano G; Cappa F; Prigione I; Pistoia V; Cohen A; Chiesa S; Gusmano R; Perfumo F
Nephrol Dial Transplant; 2001 Sep; 16(9):1807-13. PubMed ID: 11522862
[TBL] [Abstract][Full Text] [Related]
29. Soluble cytokine receptor CD30 in atopic disorders: a case-control study.
Latza U; Davis S; Wilhelm D; McKnight B; Seyfarth M; Stein H
Clin Exp Allergy; 1999 Jan; 29(1):97-104. PubMed ID: 10051708
[TBL] [Abstract][Full Text] [Related]
30. Age-dependent changes of serum soluble CD30 concentration in children.
Chrul S; Polakowska E
Pediatr Transplant; 2011 Aug; 15(5):515-8. PubMed ID: 21672104
[TBL] [Abstract][Full Text] [Related]
31. Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnancies.
Kusanovic JP; Romero R; Hassan SS; Gotsch F; Edwin S; Chaiworapongsa T; Erez O; Mittal P; Mazaki-Tovi S; Soto E; Than NG; Friel LA; Yoon BH; Espinoza J
J Matern Fetal Neonatal Med; 2007 Dec; 20(12):867-78. PubMed ID: 17853188
[TBL] [Abstract][Full Text] [Related]
32. Plasma Soluble CD30 as a Possible Marker of Adult T-cell Leukemia in HTLV-1 Carriers: a Nested Case-Control Study.
Takemoto S; Iwanaga M; Sagara Y; Watanabe T
Asian Pac J Cancer Prev; 2015; 16(18):8253-8. PubMed ID: 26745069
[TBL] [Abstract][Full Text] [Related]
33. Serum levels of soluble CD30 in chronic hepatitis B virus infection.
Fattovich G; Vinante F; Giustina G; Morosato L; Alberti A; Ruol A; Pizzolo G
Clin Exp Immunol; 1996 Jan; 103(1):105-10. PubMed ID: 8565268
[TBL] [Abstract][Full Text] [Related]
34. [Differential diagnostic and prognostic value of serum cytokines (soluble CD30, soluble interleukin-2 receptor, interleukin-10 and interleukin-6) in Hodgkin's disease and lymphosarcomas].
Iaguzhinskaia OE; Lazarev IE; Nikitin EA; Samoĭlova RS; Loginova IV; Gemdzhan EG; Novikov VA; Mamiliaeva ZKh; Pivnik AV
Ter Arkh; 2001; 73(4):45-51. PubMed ID: 11494447
[TBL] [Abstract][Full Text] [Related]
35. Maternal serum soluble CD30 is increased in pregnancies complicated with acute pyelonephritis.
Kusanovic JP; Romero R; Esoinoza J; Gotsch F; Edwin S; Chaiworapongsa T; Mittal P; Soto E; Erez O; Mazaki-Tovi S; Than NG; Friel LA; Yoon BH; Mazor M; Hassan SS
J Matern Fetal Neonatal Med; 2007 Nov; 20(11):803-11. PubMed ID: 17853184
[TBL] [Abstract][Full Text] [Related]
36. Soluble CD30 as a predictor of kidney graft outcome.
Pelzl S; Opelz G; Wiesel M; Schnülle P; Schönemann C; Döhler B; Süsal C
Transplantation; 2002 Jan; 73(1):3-6. PubMed ID: 11792970
[TBL] [Abstract][Full Text] [Related]
37. Shedding of the soluble form of CD30 from the Hodgkin-analogous cell line L540 is strongly inhibited by a new CD30-specific antibody (Ki-4).
Horn-Lohrens O; Tiemann M; Lange H; Kobarg J; Hafner M; Hansen H; Sterry W; Parwaresch RM; Lemke H
Int J Cancer; 1995 Feb; 60(4):539-44. PubMed ID: 7530238
[TBL] [Abstract][Full Text] [Related]
38. Peritransplant Soluble CD30 as a Risk Factor for Slow Kidney Allograft Function, Early Acute Rejection, Worse Long-Term Allograft Function, and Patients' Survival.
Trailin AV; Ostapenko TI; Nykonenko TN; Nesterenko SN; Nykonenko OS
Dis Markers; 2017; 2017():9264904. PubMed ID: 28694560
[TBL] [Abstract][Full Text] [Related]
39. [Serum soluble HLA-G, soluble CD30 is correlated to the time after transplantation in renal transplant recipients].
Jin Z; Xu C; Duan W; Yang J; Tian P
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Jul; 33(7):947-952. PubMed ID: 28712403
[TBL] [Abstract][Full Text] [Related]
40. Prediagnostic serum sCD27 and sCD30 in serial samples and risks of non-Hodgkin lymphoma subtypes.
Purdue MP; Lan Q; Langseth H; Grimsrud TK; Hildesheim A; Rothman N
Int J Cancer; 2020 Jun; 146(12):3312-3319. PubMed ID: 31523805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
